Virpax Pharmaceuticals, Inc. Human Resources Contracts & Agreements
25 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Consulting Agreements (5)
- Employment Agreements (10)
- Separation Agreements (2)
- First Amendment to Independent Contractor Agreement with Chaudhry U Consulting Inc (Filed With SEC on December 30, 2024)
- First Amendment to Independent Contractor Agreement with Jat Consulting Corp (Filed With SEC on December 30, 2024)
- Form of Independent Contractor Agreement, dated November 19, 2024, by and between Virpax Pharmaceuticals, Inc. and Jat Consulting Corp., the personal corporation of Mr. Jatinder... (Filed With SEC on November 22, 2024)
- Form of Independent Contractor Agreement, dated November 18, 2024, by and between Virpax Pharmaceuticals, Inc. and Chaudhry U Consulting Inc (Filed With SEC on November 20, 2024)
- Amendment to the Virpax Pharmaceuticals, Inc. 2022 Equity Incentive Plan to Increase Evergreen Provision Percentage (Filed With SEC on July 30, 2024)
- Amendment to the Virpax Pharmaceuticals, Inc. 2022 Equity Incentive Plan to Increase in Authorized Shares (Filed With SEC on July 30, 2024)
- Separation Agreement between Virpax Pharmaceuticals, Inc. and Jeffrey Gudin, MD, dated May 2, 2024 (Filed With SEC on May 2, 2024)
- Employment Agreement, dated April 7, 2021, by and between Virpax Pharmaceuticals, Inc. and Sheila Mathias (Filed With SEC on March 26, 2024)
- Employment Agreement, dated December 6, 2023, by and between Virpax Pharmaceuticals, Inc. and Gerald Bruce (Filed With SEC on December 7, 2023)
- Amendment to Employment Agreement, dated August 15, 2023, by and between Virpax Pharmaceuticals, Inc. and Anthony Mack (Filed With SEC on August 16, 2023)
- Separation agreement, dated June 18, 2023 by and between Virpax Pharmaceuticals, Inc. and Christopher Chipman (Filed With SEC on June 21, 2023)
- Employment Agreement, dated June 20, 2023, by and between Virpax Pharmaceuticals, Inc. and Vinay Shah (Filed With SEC on June 21, 2023)
- Virpax Pharmaceuticals, Inc. Form of Incentive Stock Option Grant Agreement (Filed With SEC on July 25, 2022)
- Virpax Pharmaceuticals, Inc. 2022 Omnibus Equity Incentive Plan (Filed With SEC on July 25, 2022)
- Amendment No. 1, dated March 29, 2022, to the Employment Agreement by and between Virpax Pharmaceuticals, Inc. and Jeffrey Gudin, MD, dated April 15, 2021 (Filed With SEC on March 31, 2022)
- Amendment No. 1, dated March 29, 2022, to the Employment Agreement by and between Virpax Pharmaceuticals, Inc. and Christopher M. Chipman, dated April 7, 2021 (Filed With SEC on March 31, 2022)
- Amendment No. 1, dated March 29, 2022, to the Employment Agreement by and between Virpax Pharmaceuticals, Inc. and Anthony Mack, dated September 18, 2017 (Filed With SEC on March 31, 2022)
- First Amendment to the Amended and restated Virpax Pharmaceuticals, Inc. 2017 Equity Incentive Plan, dated April 25, 2020 (Filed With SEC on August 10, 2021)
- Gudin Employment Agreement (Filed With SEC on April 19, 2021)
- Chipman Employment Agreement (Filed With SEC on April 13, 2021)
- Consulting Agreement by and between Virpax Pharmaceuticals, Inc. and Gerald Bruce, dated as of March 11, 2020 (Filed With SEC on October 9, 2020)
- Employment Agreement by and between Virpax Pharmaceuticals, Inc. and Anthony Mack, dated as of September 18, 2018 (Filed With SEC on October 9, 2020)
- Form of Incentive Stock Option Award under 2017 Equity Incentive Plan (Filed With SEC on October 9, 2020)
- Form of Nonqualified Stock Option Award under 2017 Equity Incentive Plan (Filed With SEC on October 9, 2020)
- Virpax Pharmaceuticals, Inc. 2017 Equity Incentive Plan (Filed With SEC on October 9, 2020)
